Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical, phenotypic and genotypic antimicrobial resistance profile of diabetic foot ulcer-associated bacterial isolates.

Scientific reports·2026

Same author

Inhibiting METTL3 synergizes with Notch blockade to treat ESCC by targeting cancer stemness via m6A-JAG2.

Journal of gastroenterology·2026

Same author

Author Correction: Gut microbiota-modulated glutamic acid rejuvenates the quality of oocytes deteriorated by advanced reproductive age.

EMBO molecular medicine·2026

Same author

Transcription Factors in the Pathogenesis of Schizophrenia.

Life (Basel, Switzerland)·2026

Same author

Penetration testing of a quantum key distribution system as a black box.

National science review·2026

Same author

An Integrated Approach Combining Chemical Profiling, Network Pharmacology, and In Vitro Validation to Uncover the Multitarget Mechanisms of Naokang II Decoction against Vascular Dementia.

Journal of natural products·2026

Search research articles

Related Experiment Video

Updated: Dec 23, 2025

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

Rotenone: from modelling to implication in Parkinson's disease.

Khaled Radad^1,2, Mubarak Al-Shraim¹, Ahmed Al-Emam^1,3

¹Department of Pathology, College of Medicine, King Khalid University, Abha, Saudi Arabia.

Folia Neuropathologica

|April 28, 2020

Summary

Rotenone, a natural pesticide, is investigated for its role in Parkinson's disease (PD) pathogenesis. The rotenone model in rats mimics PD features, aiding research into disease mechanisms and potential therapies.

Keywords:

Parkinson's disease neurodegeneration pesticides piscicides rotenone

More Related Videos

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Published on: October 26, 2010

The 6-hydroxydopamine Rat Model of Parkinson's Disease

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

Related Experiment Videos

Last Updated: Dec 23, 2025

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Published on: October 26, 2010

The 6-hydroxydopamine Rat Model of Parkinson's Disease

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

Area of Science:

Environmental toxicology
Neuroscience
Pharmacology

Background:

Rotenone is a naturally occurring pesticide derived from plant species.
It has been historically used for pest and fish control.
Rotenone exposure has been linked to Parkinson's disease (PD) etiopathogenesis.

Purpose of the Study:

To review recent advances in the environmental hazards of rotenone.
To discuss updates on the rotenone model of Parkinson's disease.
To evaluate rotenone's implication in PD development.

Main Methods:

Literature review of environmental applications of rotenone.
Analysis of studies utilizing the rotenone-induced Parkinson's disease model.
Synthesis of evidence linking rotenone exposure to PD.

Main Results:

Rotenone is a widely used pesticide with known environmental applications.
The rotenone model effectively replicates key PD features in rats.
Rotenone is considered a potential environmental neurotoxin implicated in PD.

Conclusions:

Rotenone's environmental use poses potential neurotoxic risks.
The rotenone model is crucial for understanding PD mechanisms.
Further research is needed to confirm rotenone's role in PD etiopathogenesis.